About Humacyte, Inc. 
Humacyte, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 33 Schemes (12.26%)
Foreign Institutions
Held by 62 Foreign Institutions (4.85%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2025)
Net Profit:
-25 Million
Pharmaceuticals & Biotechnology
USD 216 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.80
2,430.90%
-45.50






